Skip to Content

Join the 'Vasomotor Rhinitis' group to help and get support from people like you.

Vasomotor Rhinitis News

Clean Pools Can Still Pose Health Hazards

Posted 2 Jun 2016 by Drugs.com

THURSDAY, June 2, 2016 – Nothing seems better on a hot day than hopping into a cool swimming pool. But, new research might prompt you to shower first and make sure your kids don't pee in the water. Researchers from the University of South Carolina report that the disinfectants used to keep pools clean can create dangerous disinfection byproducts (DBPs) when combined with sweat, personal care products and urine. Some of these byproducts have caused genetic damage to cells in laboratory tests, while other reports have found higher rates of bladder cancer and respiratory issues in people who are around pools regularly, the researchers said. And though the study findings held true for public pools, private pools and hot tubs, the researchers flagged indoor pools and hot tubs as a top concern, too. "I never had my kids on a swim team in an indoor pool, swimming every day. I would make that ... Read more

Related support groups: Cough, Asthma, Sinusitis, Cold Symptoms, Upper Respiratory Tract Infection, Sore Throat, Cough and Nasal Congestion, Rhinitis, Respiratory Tract Disease, Croup, Vasomotor Rhinitis

Smog's Health Effects Persist for Decades, Study Finds

Posted 10 Feb 2016 by Drugs.com

TUESDAY, Feb. 9, 2016 – Air pollution can increase the risk of premature death, even decades later, one of the longest running air pollution studies suggests. British scientists found the negative health effects of air pollution – such as a higher risk of lung and heart disease – can persist for more than 30 years. The study authors suggested that more research into the long-term health effects of air pollution – often called smog – is needed. "Air pollution has well established impacts on health, especially on heart and lung disease," study author Dr. Anna Hansell, from Imperial College London, said in a university news release. "The novel aspects of our study are the very long follow-up time and the very detailed assessment of air pollution exposure, using air-quality measurements going back to the 1970s." The researchers monitored air pollution levels in areas of England and ... Read more

Related support groups: Cough, Heart Disease, Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Cold Symptoms, Upper Respiratory Tract Infection, Dyspnea, Coronary Artery Disease (CAD), Prevention of Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Acute, Cardiovascular Risk Reduction, Bronchiectasis, Respiratory Tract Disease, Croup, Respiratory Distress Syndrome, Ischemic Heart Disease, Vasomotor Rhinitis, Respiratory Failure, Infectious Heart Disease

Smog Threatens Visitors to U.S. National Parks: Report

Posted 31 Jul 2015 by Drugs.com

FRIDAY, July 31, 2015 – Air pollution afflicts many national parks across the United States, a new study suggests. Air quality in some of the parks is as bad or worse than in some major cities because of pollution from sources such as coal-fired power stations, the National Parks Conservation Association says in a new report. "Our parks remain under threat from air pollution, harming visitors' health, reducing visibility, and driving the impacts of climate change," said Ulla Reeves, manager of the association's Clean Air Campaign. Researchers examined 48 national parks with the greatest Clean Air Act protections. They discovered that 75 percent of them sometimes have "moderate" or worse ozone pollution, according to the Environmental Protection Agency's Air Quality Index. These levels are dangerous for sensitive groups, such as children with asthma. Four parks – Joshua Tree, Sequoia, ... Read more

Related support groups: Nasal Congestion, Rhinorrhea, Sore Throat, Rhinitis, Sinus Symptoms, Respiratory Tract Disease, Vasomotor Rhinitis

FDA Approves Tris Pharma's New Drug Application for Karbinal ER

Posted 3 Apr 2013 by Drugs.com

MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5mL, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up. "Karbinal ER is dosed only once every 12 hours, making it an attractive treatment option for the millions of allergy sufferers who don't respond to second-generation antihistamines and aren't satisfied with the cumbersome dosing schedules associated with the first-generation antihistamines," said Ketan Mehta, founder, President, and CEO of Tris Pharma. "The approval of Karbinal ER ... Read more

Related support groups: Allergic Reactions, Allergies, Allergic Rhinitis, Rhinitis, Allergic Urticaria, Vasomotor Rhinitis, Seasonal Allergic Conjunctivitis, Carbinoxamine, Allergic Dermatitis, Allergic Conjunctivitis, Allergic Purpura

Ask a Question

Further Information

Related Condition Support Groups

Rhinitis

Related Drug Support Groups

Palgic, Pediatex, Pediox, Arbinoxa, carbinoxamine, Histex PD, Karbinal ER, Histex IE, Cordron NR, Carboxine, Pediatex 12, Histex CT